AzTrials
AzTrials

Hernia, InguinalTISTANCT01641718

Use of Human Fibrin Glue Versus Staples for Mesh Fixation in Laparoscopic Transabdominal Preperitoneal Hernioplasty

A study testing Tissue glue and Staples in people with Hernia, Inguinal, run by Sascha Müller at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Inguinal hernia repairs belong to the most common surgical procedures worldwide. Increasingly they are performed using endoscopical techniques (laparoscopy). Many surgeons prefer to cover the hernia gap with a mesh to prevent recurrence. For it, the mesh must be fixed tightly, but tension free. Read more about this study

Who is it for?
Ages 18 to 80 years, men only
Conditions the study is for
Hernia, Inguinal
What is being tested?
Tissue glue and Staples
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteSwitzerland
Study dates
Jan 2013to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary hernia repair (no re-operation for recurrent hernia)
  • good compliance can be expected
  • informed consent

Who cannot join

  • chronic pain
  • acute pain requiring analgesic others than paracetamol or more than a single dose non-steroidal anti-inflammatory drugs treatment within 48 h before surgery
  • current treatment with psychopharmaceutical drugs
  • mental incapacity
  • known incompatibility (allergies) with the Tisseel compounds

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Cantonal Hospital St.Gallen

    Sankt Gallen, 9007

Other trials in Switzerland

About this study

Official title: Use of Human Fibrin Glue (Tisseel) Versus Staples for Mesh Fixation in Laparoscopic Transabdominal Preperitoneal Hernioplasty (TISTA)

Inguinal hernia repairs belong to the most common surgical procedures worldwide. Increasingly they are performed using endoscopical techniques (laparoscopy). Many surgeons prefer to cover the hernia gap with a mesh to prevent recurrence. For it, the mesh must be fixed tightly, but tension free. During laparoscopic surgery the mesh is fixed commonly with staples or tissue glue. However, it is not uncommon that staples cause pain at the staple sites while moving. In addition, staples can cause scarring of the abdominal wall leading to chronic pain.

Aim of the study is to provide evidence that mesh fixation with tissue glue causes less postoperative pain compared to fixation with staples.

Read more

Patients with unilateral inguinal hernia will be randomized to receive either mesh fixation with tissue glue or staples (ratio 1:1).

Patients with bilateral inguinal hernia will receive mesh fixation with tissue glue on one side and staple fixation on the other side. The side treated with tissue glue will be randomized (ratio 1:1).

Read the detailed description

______________________________________________

The inguinal hernia is the most common hernia, including 90% of all spontaneous hernias, and the inguinal hernia repair is the most frequently performed procedure in general surgery. In the United States more than 700,000 inguinal hernias are repaired annually and in Germany more than 200,000. The standard method for inguinal hernia repair, originally described by Bassini in 1889, is the closure of the inguinal canal using sutures. Due to the high recurrence rate of this technique, methods using the tension-free implantation of synthetic meshes were established. Furthermore, endoscopic/laparoscopy methods were established, in which the hernia canal is usually approached from the posterior side opposite to the anterior site in the open approach. It is still hotly debated which of these approaches and methods is the best. Among the various posterior techniques using preperitoneal mesh implantation, the transabdominal preperitoneal patch plastic repair (TAPP) and the total extraperitoneal (TEP) repair achieved the highest acceptance. There are many indications for the use of both techniques, but the TAPP is recommended especially for recurrent hernias (after open preperitoneal patch plastic) and difficult hernias (sliding or incarcerated hernias). The advantages of the TAPP are that it is easier to perform, has a better possibility of standardization, and offers the option to perform a diagnostic laparoscopy. Thus, the type of hernia can be assessed immediately on both sides and a bilateral repair can be performed without additional incisions. In general, learning TAPP is easier than TEP. Most randomized studies comparing laparoscopic with open repair found the following results for laparoscopy: reduced postoperative pain, earlier return to work, increased costs, increased operating time, longer learning period, and during the early learning phase an increased recurrence and complication rate. In summary open, mesh-based, tension-free repair remains the standard, but laparoscopic herniorrhaphy, in the hands of adequately trained surgeons, produces excellent results comparable to those of open repair.

Whether patients suffer from postoperative pain depends on many factors like the type of intervention, complications, age, and individual tolerance. In particular the type of mesh fixation employed during hernioplasty has a strong influence on postoperative pain. In a recent review mesh fixation by glue was compared to mesh fixation with staplers during endoscopic inguinal hernia repair (Surg Laparosc Endosc Percutan Tech (2010) 20:205). For the transabdominal preperitoneal patch plastic repair two randomized controlled trials, one non randomized trial and two case series were identified in this review. Although the authors found reduced postoperative pain and faster recovery after glue fixation without any significant difference in the recurrence rate, the authors still concluded: "As the overall quality of published data remains poor, further well-designed studies are needed until fibrin sealing can replace mechanical stapling as a new standard for mesh fixation." Thus well designed randomized studies comparing glue vs. staples fixation during TAPP are still warranted. Most of the previous studies applied only one mesh fixation method for patients with bilateral hernias. Only one study compared glue and stapler fixation in single patients with bilateral hernias. In this study a 2x2 design will be used, to compare the two fixation methods in patients with unilateral hernia as well as to compare the two methods in the same patient with bilateral hernias, eliminating the interindividual bias of the single hernia group. Furthermore this study focuses on the early postoperative pain, with a rather thorough coverage in the first 2 days. In many other studies the first time pain is measured is one month after surgery, which is the last time point in this study.

The main aim of this trial is to investigate the early postoperative pain after laparoscopic hernia repair in TAPP technique using either fibrin glue or staples for mesh fixation.

Being tested
Tissue glue, Staples
Keywords
Hernia, Inguinal
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tissue glueDrug

    Also called Tisseel (Baxter)

    The mesh fixation for the transabdominal preperitoneal patch plastic repair will be performed with 2 mL of tissue glue.

  • StaplesDevice

    Also called ProTack (Covidien), Securestrap (Ethicon)

    The mesh fixation for the transabdominal preperitoneal patch plastic repair will be performed with ProTack (Covidien) and Securestrap (Ethicon) staples.

Study groups in NCT01641718
Study groupRoleWhat they receive
Single sided glueExperimentalMesh is fixed with Tisseel for single sided inguinal hernias.
Receives: Drug: Tissue glue
Single sided stapledActive comparatorMesh is fixed with staples for single sided inguinal hernias.
Receives: Device: Staples
Bilateral glue rightOtherFor bilateral inguinal hernias mesh on the right side is fixed with Tisseel, on the left with staples. Experimental treatment and active comparator in the same patient.
Receives: Drug: Tissue glue; Device: Staples
Bilateral glue leftOtherFor bilateral inguinal hernias mesh on the left side is fixed with Tisseel, on the right with staples. Experimental treatment and active comparator in the same patient.
Receives: Drug: Tissue glue; Device: Staples

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain after physical stress

    Patient rates his pain on a scale from 0 to 10 (10 equals worst pain imaginable). (NRS numeric rating scale).

    Patient will be asked to bend the hip joint for 90° on the operated side (both sides for patients with bilateral hernia). Then they are asked for the pain rating (physical stress measurement).

    Measured: 24 h after surgery

Secondary outcomes (9)
  1. Pain at rest

    Patient rates his pain on a scale from 0 to 10 (10 equals worst pain imaginable). (NRS numeric rating scale).

    Patient is interviewed for pain at rest before pain measurement after physical stress.

    Measured: 4, 8, 16, 24, 32, 48 h & 1 month after surgery

  2. Pain after physical stress

    Patient rates his pain on a scale from 0 to 10 (10 equals worst pain imaginable). (NRS numeric rating scale).

    Patient will be asked to bend the hip joint for 90° on the operated side (both sides for patients with bilateral hernia). Then they are asked for the pain rating (physical stress measurement).

    Measured: 4, 8, 16, 32, 48 h & 1 month after surgery

  3. Operating time

    Time in minutes from the first skin incision to the application of dressing.

    Measured: 4 h

  4. Length of hospital stay

    Time in days (with one decimal) from start of surgery to hospital release.

    Measured: 2 weeks

  5. Postoperative analgetic requirements

    Amount (g/day) and type (paracetamol, metamizol, morphin) of analgesic required after surgery until hospital discharge.

    Measured: 1 month

  6. Incidence of persisting pain (neuralgia)

    Persisting pain (neuralgia) is defined by the presence of intermittent hyperesthesia, burning sensation or jabbing pain in the ipsilateral inguinal area nerves (genitofemoral nerve, lateral cutaneous femoral nerve, ilioinguinal and iliohypogastric nerve).

    Evaluation for chronic pain (neuralgia) will be performed during the 1 month follow-up visit. The degree of pain will measured as described above.

    Measured: 1 month

  7. Postoperative morbidity

    • Wound infection (defined as those treated without further surgery and identified by clinical examination without microbiological confirmation)
    • haematoma or seroma formation (identified by clinical examination alone before discharge from hospital, without the requirement for radiological confirmation)
    • Re-operation (Need for re-operation during patients' initial hospital stay)
    • Bleeding
    • Urinary retention, urinary tract infection
    • Pulmonary infection
    • Any serious deviation from the normal postoperative course

    Measured: 1 month

  8. Medical leave of absence

    Time in days from hospital discharge to first working day. All patients will be encouraged to return to work as soon as possible, irrespective of their profession. Time to return to work will be obtained during 1 month follow-up visit. If still on medical leave of absence at this time, patients will be later contacted by phone to obtain the day of return to work. Depending on the expected course of recovery these calls will be performed in a weekly or biweekly fashion.

    Measured: 2 months

  9. Economic impact

    Will be calculated using the following factors:

    • Cost for glue, staples and instruments to apply glue or staples
    • If relevant: cost for increased operating time for the "slower" mesh fixation technique
    • length of hospital stay (cost/day)
    • medical leave of absence (converted into a monetary amount using an average salary)

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2012 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2014
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01641718
Sponsor's protocol ID
TISTA
Acronym
TISTA
Status last verified
Aug 2023
First submitted
29 Jun 2012
Last updated
8 Aug 2023
Results posted
No
Data monitoring committee
No

Publications

  • Muller SA, Warschkow R, Beutner U, Luthi C, Ukegjini K, Schmied BM, Tarantino I. Use of human fibrin glue (Tisseel) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty (TISTA): a randomized controlled trial (NCT01641718). BMC Surg. 2014 Apr 1;14:18. doi: 10.1186/1471-2482-14-18.

    PubMed 24690207

Questions about this trial

What is this clinical trial studying?

A study testing Tissue glue and Staples in people with Hernia, Inguinal, run by Sascha Müller at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain after physical stress (time frame: 24 h after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01641718, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in